Search - tctmd.com

Displaying 661 - 680 of 980

Sort: Relevancy | Date

Presentation TCT 2016

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

Presenter: Sorin J. Brener, Franz-Josef Neumann, Usman Baber

October 30, 2016

Presentation TCT 2016

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

Presentation TCT 2016

In-depth Cardiac Structure, Conduction System, and Hemodynamic Review of the Normal Heart Matched With Interactive Cadaver Heart Dissection by the Pathologist

Presenter: Thomas H. Maloney, Robert Kutys, Tim J. Lapp, Maria E. Romero

October 29, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Conference News TCT 2015

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Yael L. Maxwell

October 16, 2015

Presentation TCT 2015

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Doris A. Taylor

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Presenter: Eric R. Bates, Spencer B. King III, Sanjay Kaul

October 13, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

Advertisement

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

In-depth Cardiac Structure, Conduction System, and Hemodynamic Review of the Normal Heart Matched With Interactive Cadaver Heart Dissection by the Pathologist

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI

Debate: Is It Necessary to Implant 3-D Cardiac Structures? In Which Setting? Yes, With Cadaveric Matrices Native Myocardial Architecture Is Mandatory!

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content